Chaobin Zhang,Yuhang Wang,Jianding Peng,Xiaotian Wen,Youwen Zhang,Kejun Li,Hanjian Du,Xiaofei Hu
Abstract:Background: In recent years, infectious diseases like COVID-19 have had profound global socio-economic impacts. mRNA vaccines have gained prominence due to their rapid development, industrial adaptability, simplicity, and responsiveness to new variants. Notably, the 2023 Nobel Prize in Physiology or Medicine recognized significant contributions to mRNA vaccine research. Methods: Our study employed a comprehensive bibliometric analysis using the Web of Science Core Collection (WoSCC) database, encompassing 5,512 papers on mRNA vaccines from 2003 to 2023. We generated cooperation maps, co-citation analyses, and keyword clustering to evaluate the field's developmental history and achievements. Results: The analysis yielded knowledge maps highlighting countries/institutions, influential authors, frequently published and highly cited journals, and seminal references. Ongoing research hotspots encompass immune responses, stability enhancement, applications in cancer prevention and treatment, and combating infectious diseases using mRNA technology. Conclusions: mRNA vaccines represent a transformative development in infectious disease prevention. This study provides insights into the field's growth and identifies key research priorities, facilitating advancements in vaccine technology and addressing future challenges.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to decode the trends in mRNA vaccine research through comprehensive bibliometric analysis. Specifically, the paper aims to:
1. **Discover the trends in mRNA vaccine research over the past 20 years**: By analyzing relevant literature published between 2003 and 2023, reveal the research dynamics and development process in this field.
2. **Focus on the contributions of Nobel laureates and their institutions in this field and visualize them**: Pay special attention to the contributions of Katalin Karikó and Drew Weissman in mRNA vaccine research, and show their influence through cooperation network diagrams and citation analysis.
3. **Identify challenging issues and research hotspots related to mRNA vaccines**: Through keyword clustering and co - citation analysis, determine current research priorities and future research directions.
4. **Construct a knowledge graph in this field**: Generate country/institution cooperation maps, co - citation analysis, and keyword clustering to systematically present the research results and key references in this field.
5. **Provide valuable insights for future related research**: Through the above - mentioned analysis, provide guidance for researchers, promote the development of mRNA vaccine technology, and meet future challenges.
### Main methods
- **Data sources**: Obtain literature records on mRNA vaccines between 2003 and 2023 from the Web of Science Core Collection (WoSCC) database.
- **Search strategies**: Use keywords such as "mRNA Vaccine", "mRNA Vaccines", "mRNA Vaccination", "RNA Vaccination", "RNA Vaccine", etc. for searching, and limit the document types to articles and reviews.
- **Analysis tools**: Use CiteSpace, VOSviewer, and Bibliometrix R Package software for data analysis, including country/region analysis, institution analysis, co - cited author analysis, journal co - citation analysis, literature co - citation and clustering analysis, keyword and emerging trend analysis, etc.
### Main results
- **Annual publication output**: Between 2003 and 2023, a total of 4,406 literature related to mRNA vaccines were published, of which 3,598 were articles (81.66%) and 808 were reviews (18.34%). Between 2019 - 2020, the number of publications and citations increased significantly, followed by exponential growth between 2020 - 2022, but decreased in 2023.
- **Contributions of countries and regions**: The United States, China, and Italy made the greatest contributions in this field, with 1,368, 487, and 454 literature published respectively. Countries in North America, Europe, and Asia made significant contributions, while most countries in other regions published fewer literature.
- **Institutional contributions**: Harvard University, the University of California system, and Harvard Medical School are the institutions that published the most literature, with 160, 121, and 115 published respectively. The University of Pennsylvania ranks fifth, with 107 literature published.
- **Authors and co - cited authors**: The most active author is Drew Weissman (41 articles), followed by Norbert Pardi (38 articles) and Ugur Sahin (36 articles). The author with the highest number of co - citations is Ugur Sahin (3,203 times).
- **Contributions of Nobel laureates**: Katalin Karikó and Drew Weissman made important contributions in the fields of nucleoside/base modification and lipid nanoparticle application, and their institution, the University of Pennsylvania, also performed well in these fields.
- **Journal and co - citation analysis**: "Vaccines" is the most active journal, with 444 literature published. "New England Journal of Medicine" is the most influential journal, with 12,636 citations.
- **Keyword analysis**: The most commonly used keywords are "mRNA vaccine", "immunogenicity", and "COVID - 19", which appeared 682, 272, and 271 times respectively. Research hotspots include the application of mRNA vaccines in infectious diseases, the human body's response to mRNA vaccines, mRNA vaccine delivery systems, and mRNA cancer vaccines.
### Conclusion